Anti-bribery policy

November 2017

1. PURPOSE AND OBJECTIVES

The adverse economic and social consequences of bribery and corruption are a
major deterrent to development, everywhere in the world.

Sanofi has zero-tolerance for bribery. Sanofi has been engaged for many years in
fostering throughout its organization, but also in its relationships with external
stakeholders, an ethical culture aiming at reaching the highest standards in terms of
responsibility and business integrity.

The purpose of this Policy is to establish guidance for Sanofi Employees and Third
Parties interacting with Sanofi to comply with applicable Anti-corruption and Anti-
bribery Laws and Regulations, as well as to promote a culture of ethics and integrity.

This policy also aims at protecting Sanofi and Sanofi Employees’ reputation and at
avoiding potential civil and criminal fines.

2. SCOPE

This Policy is global in scope and applies to Sanofi worldwide, all Sanofi Employees
and Third Parties engaged in activities with Sanofi.

3. DEFINITIONS AND ACRONYMS

3.1 DEFINITIONS

Anti-corruption and Anti-bribery Laws and Regulations: Any applicable law or

regulation addressing corruption and/or bribery, including, but not limited to the
French Criminal Code and the French Law of December 9th 2017 on Transparency,
the Fight Against Corruption and the Modernization of the Economy (Sapin 2 Law)
the U.S. Foreign Corrupt Practices Act (FCPA) and the U.K. Bribery Act (UKBA), as
well as applicable international conventions, including, but not limited to, the
Organization for Economic Co-operation and Development Anti-Bribery Convention
and the United Nations Convention against Corruption.

Anything of value: may include, but is not limited to:

 • Cash,
• Gifts,
• Entertainment, accommodations and meals,
• Travel expenses,
• Services,
• Employment offers,
• Loans,
• Donations or contributions, and
• Any other transfer of value, even if nominal in value.

Code of Ethics: the Sanofi Code of Ethics.

Facilitating Payments: Payments to any Government Organization or Government

Official, made in order to expedite or secure performance of non-discretionary,
routine governmental actions (e.g., processing a visa, customs invoice, or other
governmental paper)

Government or Government Organization: any department, any administration,

any agency controlled in whole or in part by the government, any public international
organizations and their agencies or instrumentality of a government (including a
government-controlled enterprise), and any organization considered to be a
government department or administrative office under any local law..

HealthCare Professional: An individual, member of the medical, dental, pharmacy

or nursing professions or any other person who in the course of his or her
professional activities may prescribe, purchase, dispense, administer or recommend
a Sanofi product. Examples include physicians, pharmacists, nurses, investigators
(may include such individuals in training e.g. students). Healthcare Professionals
working in a Government or in a Government Organizations are considered as
Government Officials.

Joint-Venture / Partnership: means an entity in which Sanofi has the direct or

indirect ownership of fifty percent (50%) or less of the equity having the power to vote
on or direct the affairs of the entity are considered as Third Parties.

Person: Any Government Official(s), Sanofi customer(s) or business relation(s).

Government Official: Individuals, in the following categories:

• Any officer or employee (including any person nominated or appointed to be
an officer or employee even if part-time) of a Government or a Government
Organization;

2
 • Any person acting in an official capacity on behalf of a Government or a
Government Organization;
• Any officer or employee of a company or business owned in whole or part by a
Government or a Government Organization;
• Any officer or employee of a public international organization, such as the
World Bank or the United Nations;
• Any officer or employee of a political party or any person acting in an official
capacity on behalf of a political party; and/or
• Any candidate for political office.

Sanofi: The Sanofi parent company with its headquarters in Paris - France and any
corporation or business entity which, directly or indirectly, controls, is controlled or is
under common control of the Sanofi parent company. The term 'control' means direct
or indirect ownership of more than fifty percent (50%) of the equity having the power
to vote on or direct the affairs of the entity.

Sanofi employee: Any employee of the company, whether full time or part time,
temporary or trainee and any other employee category according to local regulation.

Third Parties: any individuals, companies, associations, partnerships, or other

entities retained to act on behalf of or for the benefit of Sanofi. The term includes, but
is not limited to agents, consultants, lobbyists, suppliers, distributors, resellers.

Trafic d’influence: Article 433-2 of the French Criminal Code defines “Trafic
d’Influence” (influence peddling) as the fact, for any person, to solicit or accept at any
time, directly or indirectly, any offer, promise, donation, gift or benefit whatsoever, for
himself or others, for the purpose of misusing or abusing its actual or perceived
influence for the purpose of obtaining distinctions, employment, markets or any other
favorable decision from a Government or a Government Organization. Each time the
words bribery and or corruption are used in this Policy, they include “Trafic
d’influence”.

3.2 ACRONYMS

None

4 REFERENCES
Code of Ethics

Global Policy Organization of and Contribution to Events

3
Global Policy Global Procurement

Global Policy Donations and Other Contributions to Organizations

Global Policy Service Engagement with Scientific External Experts

Global Operational Standard Conducting Anti-Bribery Due Diligence on Third Parties

Global Policy Responsible Lobbying

Global Policy Entertainment of Third Parties

Global Policy Accepting and/or Providing Gifts or Reminder Items

Global Operational Standard Reportable Consulting Agreements

Global Policy Conflict of Interest

Global Policy Interaction with Patients, Patient Advocate and Groups

Global Operational Standard Advisory Boards composed of Scientific External Expert

Global Policy Alerts Management

Global Policy Corrective and/or Disciplinary Actions

5 REQUIREMENTS

5.1 PROHIBITED INTERACTIONS

Sanofi, Sanofi Employees and Third Parties are prohibited from giving, promising to
give or offering to give Anything of Value, to any Person for the purpose of
influencing any act or decision of the Person, and/or the entity the Person represents,
in order to secure an improper advantage or to otherwise obtain or retain business
for Sanofi.

The above prohibition also applies to indirect provision of Anything of Value to any
Person, including but not limited via the use of intermediaries or relatives of the
Person. Sanofi, Sanofi Employees and Third Parties are prohibited from making,
offering to make, or authorizing a payment to any person or entity (e.g., suppliers,
agent, distributor or intermediary) with knowledge that all or part of the payment will
be offered or given to a Person to secure an improper advantage or to obtain or
retain business.

4
The prohibition set forth in this Policy also applies should Sanofi Employees use their
own personal funds or assets.

Sanofi prohibits Facilitating Payments, even when legally permitted.

5.2 PERMITTED INTERACTIONS

In order to promote a culture of ethics and integrity, as well as, to comply with all
applicable Anti-corruption Anti-bribery Laws and Regulations, Sanofi has
implemented a comprehensive set of policies and standards defining clear rules that
must be complied with by all Sanofi Employees and, when applicable, by Third
Parties.

These policies and standards govern certain activities to ensure they are
implemented for genuine and legitimate business reasons and include specific
provisions aiming at preventing bribery and corruption.

These policies and standards include:

• Organization of and Contribution to Events
• Global Procurement
• Donations and Other Contributions to Organizations
• Service Engagement with Scientific External Experts
• Conducting Anti-Bribery Due Diligence on Third Parties
• Responsible Lobbying
• Entertainment of Third Parties
• Accepting and/or Providing Gifts or Reminder Items
• Reportable Consulting Agreements
• Conflict of Interest of Employees
• Interaction with Patients, Patient Advocate and Groups
• Advisory Boards composed of Scientific External Experts

This set of policies and standards is continuously assessed, updated and

complemented if needed, to ensure adequacy with the evolution of the legal and
regulatory framework, as well as, of the risk associated with the Sanofi activities.

These policies and standards are not meant to be exhaustive in addressing all the
circumstances that may arise. If a particular situation is not covered or the provisions
of the policies and standards are not clear to a Sanofi Employee, the latter must

5
consult his or her manager and or the Legal and Ethics & Business Integrity
Department.

5.3 ANTI-BRIBERY DUE DILIGENCE ON THIRD PARTIES

As detailed in the Operational Standard “Conducting Anti-Bribery Due Diligence on

Third Parties”, Sanofi conducts “risk-based” anti-bribery Due Diligence on Third
Parties to avoid or to mitigate the risk of Third-Party corrupt conduct.

Furthermore, appropriate anti-corruption and anti-bribery due diligence must be

conducted, in accordance with relevant business practices and Sanofi policies and
procedures, in advance of making any investment in a non-Sanofi business entity or
entering into any Joint-Venture/ Partnership agreement.

6 RESPONSIBILITIES

6.1 GENERAL RESPONSIBILITIES

Fostering a culture of integrity throughout the organization and clearly communicating

on Sanofi’s expectations contribute to reduce the risk of bribery and corruption.
Managers are responsible to contribute to the understanding by all members of their
teams of what bribery is, as well as, how to prevent it.

Each Sanofi Employee is responsible to comply with this Policy and is expected to
perform the trainings made available by the Ethics & Business Integrity Department.

Each Sanofi Employee has a duty to prevent breaches of this Policy by reporting any
questionable situation according to the Sanofi Code of Ethics and the Alerts
Management policy.

According to the provisions of article 17 of the French Law of December 9th 2017 on
Transparency, the Fight Against Corruption and the Modernisation of the Economy,
this policy could be integrated within the company legal entities and facilities’ internal
regulations (“règlement intérieur”).

6.2 FINANCIAL AND ACCOUNTING CONTROLS

In accordance with all relevant rules, regulations and internal procedures, Sanofi
requires that all books, records, and accounts are kept in reasonable detail to
accurately and fairly reflect all transactions and dispositions of assets and that
adequate internal controls are maintained to provide reasonable assurance that

6
management is aware of, and directing, all transactions ethically and in compliance
with applicable Sanofi Policies and Standards.

6.3 CONSEQUENCES OF NON-COMPLIANCE WITH THIS POLICY

Violations of Anti-corruption and Anti-bribery Laws and Regulations may result in civil
and criminal penalties for Sanofi and Sanofi Employees, in addition to disciplinary
actions against Sanofi Employees according to the company legal entities and
facilities’ internal regulations (“règlement intérieur”) and the Corrective and/or
disciplinary actions policy.

End of Document